Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach

BACKGROUND: Intravenous augmentation therapy is the only specific treatment available for emphysema associated with alpha-1 antitrypsin deficiency. Despite large observational studies and limited interventional studies there remains controversy about the efficacy of this treatment due to the impract...

Descripción completa

Detalles Bibliográficos
Autores principales: Stockley, Robert A, Miravitlles, Marc, Vogelmeier, Claus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852071/
https://www.ncbi.nlm.nih.gov/pubmed/24063809
http://dx.doi.org/10.1186/1750-1172-8-149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852071/
https://www.ncbi.nlm.nih.gov/pubmed/24063809
http://dx.doi.org/10.1186/1750-1172-8-149

Ejemplares similares